SecBot SecBot
Insider Cluster (4 insiders) ·Filed Feb 27, 2026

LRMR

Larimar Therapeutics, Inc.
BULLISH
Impact 8/10
Horizonweeks Processed8mo ago
Insider cluster: 4 insiders, $6.0M total
Actionable Insight ▲ Bullish

This level of concentrated insider buying, especially one transaction over $5M, is rare and typically signals strong conviction in near-term value. Traders should watch for upcoming clinical updates or catalysts that may have prompted this activity.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$5.31
T+0 close · Feb 26, 2026 · via day close
Latest settled
−34.65%
T+60 · $3.47
Vs SPY
−44.04%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Feb 27 $5.31entry
  2. T+1 · 9mo ago −1.51%α −1.56% · $5.23
  3. T+5 · 9mo ago −1.69%α +0.29% · $5.22
  4. T+20 · 8mo ago −12.99%α −5.44% · $4.62
  5. T+60 · 6mo ago −34.65%α −44.04% · $3.47
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Four insiders at Larimar Therapeutics collectively purchased $6.07 million in shares over a single day at $5 per share, including a major $5.42 million open-market buy by an insider. This represents a strong, coordinated vote of confidence from corporate insiders.

Key Financial Metrics

Direction
buying
Total Value
$6.1M
Insiders
4

Key Facts

  • Insiders purchased a total of $6.07 million in LRMR stock on February 27, 2026.
  • The largest transaction was a $5.42 million open-market purchase of 1,084,010 shares.
  • All transactions were open-market buys (Form 4 code 'P'), indicating direct cash investment.
  • Total insider buying represents approximately 1.34% of the company's $454M market cap, a materially significant level.

Financial Impact

$6.07 million in insider buying at $5/share, equivalent to 1.34% of market capitalization

market sentimentinsider ownershipfloat reduction

Risk Factors

  • Insider purchases do not guarantee positive outcomes, the stock remains high-risk, especially for a biotech with no commercial products.
  • Buying could be based on non-public information that may not materialize as expected.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (4 trades, 7d window)cluster-LRMR-1772498798624

US Market Status

Market Closed · Opens in 6h 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 2, 2026